Aramark <ARMK.N>: Deutsche Bank raises target price to $74 from $65
ARMK•Related News
Acumen Pharmaceuticals Q2 net loss widens, misses analyst estimates
ABOS•
Local Bounti Q2 revenue rises on higher production and sales
LOCL•
Can-Fite says Phase III namodenoson trial in advanced liver cancer advances under FDA, EMA guidance
CANF•
Vor Biopharma Inc. <VOR.O>: Wedbush raises target price to $27 from $18
VOR•
Local Bounti Q2 FY26 net loss narrows 8.15% to 19.82 million; sales rise 14% to 13.85 million
LOCL•